Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

This study explores how quality of life is affected in people who have been told they have an abnormal protein in their blood (monoclonal gammopathy or smoldering myeloma) but have not yet developed active multiple myeloma. **You may be eligible if...** - You are 18 or older - You have been diagnosed with monoclonal gammopathy of undetermined significance (MGUS) — an abnormal protein in your blood that is low-level and not yet causing disease - OR you have smoldering multiple myeloma — a higher level of abnormal protein but still without active disease symptoms **You may NOT be eligible if...** - You have active multiple myeloma (with organ damage or symptoms) - You have been diagnosed with amyloidosis Talk to your doctor to see if this trial is right for you.